Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin for Spontaneous Voiding after Acute Urinary Retention
NCT00453908Phase 3Terminated
- Sponsor
- Sanofi
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alfuzosin in acute urinary retention, sponsored by Sanofi. Started May 2004; status: terminated.
02
Drugs
alfuzosin
03
Conditions
acute urinary retention
Beyond the preview
Go deeper on NCT00453908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453908.